These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32373773)

  • 1. Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of
    Kobayashi S; Tanigawa J; Kondo H; Nabatame S; Maruoka A; Sho H; Tanikawa K; Inui R; Otsuki M; Shimomura I; Ozono K; Hashimoto K
    J Endocr Soc; 2020 May; 4(5):bvaa041. PubMed ID: 32373773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel synonymous and missense variants in FGFR1 causing Hartsfield syndrome.
    Courage C; Jackson CB; Owczarek-Lipska M; Jamsheer A; Sowińska-Seidler A; Piotrowicz M; Jakubowski L; Dallèves F; Riesch E; Neidhardt J; Lemke JR
    Am J Med Genet A; 2019 Dec; 179(12):2447-2453. PubMed ID: 31512363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism.
    Dhamija R; Kirmani S; Wang X; Ferber MJ; Wieben ED; Lazaridis KN; Babovic-Vuksanovic D
    Am J Med Genet A; 2014 Sep; 164A(9):2356-9. PubMed ID: 24888332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly.
    Simonis N; Migeotte I; Lambert N; Perazzolo C; de Silva DC; Dimitrov B; Heinrichs C; Janssens S; Kerr B; Mortier G; Van Vliet G; Lepage P; Casimir G; Abramowicz M; Smits G; Vilain C
    J Med Genet; 2013 Sep; 50(9):585-92. PubMed ID: 23812909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel heterozygous mutation in the extracellular domain of
    Takagi M; Miyoshi T; Nagashima Y; Shibata N; Yagi H; Fukuzawa R; Hasegawa T
    Hum Genome Var; 2016; 3():16034. PubMed ID: 27790375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway.
    Palumbo P; Petracca A; Maggi R; Biagini T; Nardella G; Sacco MC; Di Schiavi E; Carella M; Micale L; Castori M
    Eur J Hum Genet; 2019 Jul; 27(7):1113-1120. PubMed ID: 30787447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome.
    Hong S; Hu P; Marino J; Hufnagel SB; Hopkin RJ; Toromanović A; Richieri-Costa A; Ribeiro-Bicudo LA; Kruszka P; Roessler E; Muenke M
    Hum Mol Genet; 2016 May; 25(10):1912-1922. PubMed ID: 26931467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otorhinolaryngologic manifestations of Hartsfield syndrome: Case series and review of literature.
    Oliver JD; Menapace DC; Cofer SA
    Int J Pediatr Otorhinolaryngol; 2017 Jul; 98():4-8. PubMed ID: 28583501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
    Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations.
    Akkuş G; Kotan LD; Durmaz E; Mengen E; Turan İ; Ulubay A; Gürbüz F; Yüksel B; Tetiker T; Topaloğlu AK
    J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):95-100. PubMed ID: 28008864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submicroscopic deletion involving the fibroblast growth factor receptor 1 gene in a patient with combined pituitary hormone deficiency.
    Fukami M; Iso M; Sato N; Igarashi M; Seo M; Kazukawa I; Kinoshita E; Dateki S; Ogata T
    Endocr J; 2013; 60(8):1013-20. PubMed ID: 23657145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 Analyses in Four Patients with Hypogonadotropic Hypogonadism with Split-Hand/Foot Malformation: Implications for the Promoter Region.
    Ohtaka K; Fujisawa Y; Takada F; Hasegawa Y; Miyoshi T; Hasegawa T; Miyoshi H; Kameda H; Kurokawa-Seo M; Fukami M; Ogata T
    Hum Mutat; 2017 May; 38(5):503-506. PubMed ID: 28087897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of craniopharyngiomas: endocrinological results.
    Honegger J; Buchfelder M; Fahlbusch R
    J Neurosurg; 1999 Feb; 90(2):251-7. PubMed ID: 9950495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1.
    Trarbach EB; Teles MG; Costa EM; Abreu AP; Garmes HM; Guerra G; Baptista MT; de Castro M; Mendonca BB; Latronico AC
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):371-6. PubMed ID: 19489874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing facilitates prepubertal diagnosis of congenital hypogonadotropic hypogonadism.
    Xu C; Lang-Muritano M; Phan-Hug F; Dwyer AA; Sykiotis GP; Cassatella D; Acierno J; Mohammadi M; Pitteloud N
    Clin Genet; 2017 Aug; 92(2):213-216. PubMed ID: 28195315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective.
    Doknic M; Pekic S; Civcic M; Popovic V
    Hormones (Athens); 2012; 11(2):189-98. PubMed ID: 22801565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
    Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
    J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.